Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (341-350 of 590) with videos related to

Pageof 59
Sort By:
Journal of Acquired Immune Deficiency Syndromes|October 1, 1994
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug usersA A Boccellari, D B Chambers, J W Dilley, et al.
Clinical Genitourinary Cancer|December 3, 2017
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate CancerNeal D Shore, Ronald F Tutrone, Neil F Mariados, et al.
Targeted Oncology|December 6, 2022
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for MetastasesGordon Brown, Laurence Belkoff, Jason M Hafron, et al.
Therapeutic Advances in Medical Oncology|May 25, 2026
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancerMehmet A Bilen, Benjamin H Lowentritt, Sabree Burbage, et al.
The Journal of Biological Chemistry|September 18, 2001
The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activityA P Bijnens, A Gils, J M Stassen, et al.
The Journal of Surgical Research|October 4, 2011
An evaluation of surgical site infections by wound classification system using the ACS-NSQIPGezzer Ortega, Daniel S Rhee, Dominic J Papandria, et al.
The Journal of Clinical Investigation|May 1, 1995
Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitroD T Eitzman, W P Fay, D A Lawrence, et al.
BJU International|March 19, 2016
Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancerNeal D Shore, Franklin Chu, Judd Moul, et al.
Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.
Molecular Psychiatry|May 24, 2000
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology ConsortiumN L Johnston-Wilson, C D Sims, J P Hofmann, et al.
Pageof 59

Showing results (341-350 of 590) with videos related to

Sort By:
Pageof 59
Journal of Acquired Immune Deficiency Syndromes|October 1, 1994
Relationship of beta 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug usersA A Boccellari, D B Chambers, J W Dilley, et al.
Clinical Genitourinary Cancer|December 3, 2017
eRADicAte: A Prospective Evaluation Combining Radium-223 Dichloride and Abiraterone Acetate Plus Prednisone in Patients With Castration-Resistant Prostate CancerNeal D Shore, Ronald F Tutrone, Neil F Mariados, et al.
Targeted Oncology|December 6, 2022
Coadministration of Apalutamide and Relugolix in Patients with Localized Prostate Cancer at High Risk for MetastasesGordon Brown, Laurence Belkoff, Jason M Hafron, et al.
Therapeutic Advances in Medical Oncology|May 25, 2026
Real-world comparative effectiveness of apalutamide versus enzalutamide for prostate-specific antigen response in metastatic castration-sensitive prostate cancerMehmet A Bilen, Benjamin H Lowentritt, Sabree Burbage, et al.
The Journal of Biological Chemistry|September 18, 2001
The distal hinge of the reactive site loop and its proximity: a target to modulate plasminogen activator inhibitor-1 activityA P Bijnens, A Gils, J M Stassen, et al.
The Journal of Surgical Research|October 4, 2011
An evaluation of surgical site infections by wound classification system using the ACS-NSQIPGezzer Ortega, Daniel S Rhee, Dominic J Papandria, et al.
The Journal of Clinical Investigation|May 1, 1995
Peptide-mediated inactivation of recombinant and platelet plasminogen activator inhibitor-1 in vitroD T Eitzman, W P Fay, D A Lawrence, et al.
BJU International|March 19, 2016
Polymer-delivered subcutaneous leuprolide acetate formulations achieve and maintain castrate concentrations of testosterone in four open-label studies in patients with advanced prostate cancerNeal D Shore, Franklin Chu, Judd Moul, et al.
Future Oncology (London, England)|April 29, 2026
Real-world clinical outcomes in patients with biochemical recurrence after local therapy for non-metastatic prostate cancerNeal D Shore, Nasreen Khan, Rana R McKay, et al.
Molecular Psychiatry|May 24, 2000
Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. The Stanley Neuropathology ConsortiumN L Johnston-Wilson, C D Sims, J P Hofmann, et al.
Pageof 59